130 related articles for article (PubMed ID: 38237865)
21. The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes.
Xu M; Tan J; Dong W; Zou B; Teng X; Zhu L; Ge C; Dai X; Kuang Q; Zhong S; Lai L; Yi C; Tang T; Zhao J; Wang L; Liu J; Wei H; Sun Y; Yang Q; Li Q; Lou D; Hu L; Liu X; Kuang G; Luo J; Xiong M; Feng J; Zhang C; Wang B
Nat Commun; 2022 Feb; 13(1):1052. PubMed ID: 35217669
[TBL] [Abstract][Full Text] [Related]
22. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway.
Su J; Yan Y; Qu J; Xue X; Liu Z; Cai H
Oncol Rep; 2017 Mar; 37(3):1565-1572. PubMed ID: 28184934
[TBL] [Abstract][Full Text] [Related]
23. Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice.
Li K; Zhang K; Wang H; Wu Y; Chen N; Chen J; Qiu C; Cai P; Li M; Liang X; Su D
Metabolism; 2021 Jan; 114():154349. PubMed ID: 32888949
[TBL] [Abstract][Full Text] [Related]
24. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
[TBL] [Abstract][Full Text] [Related]
25. Tripartite motif 38 alleviates the pathological process of NAFLD-NASH by promoting TAB2 degradation.
Yao X; Dong R; Hu S; Liu Z; Cui J; Hu F; Cheng X; Wang X; Ma T; Tian S; Zhang XJ; Hu Y; Bai L; Li H; Zhang P
J Lipid Res; 2023 Jul; 64(7):100382. PubMed ID: 37116711
[TBL] [Abstract][Full Text] [Related]
26. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.
Li K; Wang F; Cao WB; Lv XX; Hua F; Cui B; Yu JJ; Zhang XW; Shang S; Liu SS; Yu JM; Han MZ; Huang B; Zhang TT; Li X; Jiang JD; Hu ZW
Cancer Cell; 2017 May; 31(5):697-710.e7. PubMed ID: 28486108
[TBL] [Abstract][Full Text] [Related]
27. A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis.
Jin K; Shi Y; Zhang H; Zhangyuan G; Wang F; Li S; Chen C; Zhang J; Wang H; Zhang W; Sun B
J Hepatol; 2023 Aug; 79(2):403-416. PubMed ID: 37040844
[TBL] [Abstract][Full Text] [Related]
28. The critical role of BTRC in hepatic steatosis as an ATGL E3 ligase.
Qi W; Fang Z; Luo C; Hong H; Long Y; Dai Z; Liu J; Zeng Y; Zhou T; Xia Y; Yang X; Gao G
J Mol Cell Biol; 2024 Apr; 15(10):. PubMed ID: 37873692
[TBL] [Abstract][Full Text] [Related]
29. The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis.
Yan FJ; Zhang XJ; Wang WX; Ji YX; Wang PX; Yang Y; Gong J; Shen LJ; Zhu XY; Huang Z; Li H
Hepatology; 2017 May; 65(5):1492-1511. PubMed ID: 27981609
[TBL] [Abstract][Full Text] [Related]
30. F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit.
Liu Z; Chen NY; Zhang Z; Zhou S; Hu SY
World J Gastroenterol; 2023 Jul; 29(28):4433-4450. PubMed ID: 37576703
[TBL] [Abstract][Full Text] [Related]
31. The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases.
Prudente S; Sesti G; Pandolfi A; Andreozzi F; Consoli A; Trischitta V
Endocr Rev; 2012 Aug; 33(4):526-46. PubMed ID: 22577090
[TBL] [Abstract][Full Text] [Related]
32. TRIB3 enhances cell viability during glucose deprivation in HEK293-derived cells by upregulating IGFBP2, a novel nutrient deficiency survival factor.
Örd T; Örd D; Adler P; Vilo J; Örd T
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2492-505. PubMed ID: 26094770
[TBL] [Abstract][Full Text] [Related]
33. TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target.
Yu JJ; Zhou DD; Yang XX; Cui B; Tan FW; Wang J; Li K; Shang S; Zhang C; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Huang B; Hua F; Hu ZW
Nat Commun; 2020 Jul; 11(1):3660. PubMed ID: 32694521
[TBL] [Abstract][Full Text] [Related]
34. Tribble 3, a novel oxidized low-density lipoprotein-inducible gene, is induced via the activating transcription factor 4-C/EBP homologous protein pathway.
Shang YY; Zhong M; Zhang LP; Guo ZX; Wang ZH; Zhang Y; Deng JT; Zhang W
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):51-5. PubMed ID: 19566842
[TBL] [Abstract][Full Text] [Related]
35. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
Yin X; Liu Z; Wang J
Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
[TBL] [Abstract][Full Text] [Related]
36. Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways.
Tao Q; Tianyu W; Jiangqiao Z; Zhongbao C; Xiaoxiong M; Long Z; Jilin Z
Int J Biol Sci; 2019; 15(8):1618-1629. PubMed ID: 31360105
[TBL] [Abstract][Full Text] [Related]
37. Ufmylation on UFBP1 alleviates non-alcoholic fatty liver disease by modulating hepatic endoplasmic reticulum stress.
Mao Z; Ma X; Jing Y; Shen M; Ma X; Zhu J; Liu H; Zhang G; Chen F
Cell Death Dis; 2023 Sep; 14(9):584. PubMed ID: 37660122
[TBL] [Abstract][Full Text] [Related]
38. Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4.
Zhao GN; Zhang P; Gong J; Zhang XJ; Wang PX; Yin M; Jiang Z; Shen LJ; Ji YX; Tong J; Wang Y; Wei QF; Wang Y; Zhu XY; Zhang X; Fang J; Xie Q; She ZG; Wang Z; Huang Z; Li H
Nat Med; 2017 Jun; 23(6):742-752. PubMed ID: 28481357
[TBL] [Abstract][Full Text] [Related]
39. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway.
Hong B; Zhou J; Ma K; Zhang J; Xie H; Zhang K; Li L; Cai L; Zhang N; Zhang Z; Gong K
Int J Biol Sci; 2019; 15(3):587-597. PubMed ID: 30745845
[TBL] [Abstract][Full Text] [Related]
40. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
